Estimating hip fracture morbidity, mortality and costs

被引:691
作者
Braithwaite, RS
Col, NF
Wong, JB
机构
[1] Univ Pittsburgh, Montefiore Med Ctr, Div Gen Internal Med, Sect Decis Sci & Clin Syst Modeling,Dept Med,Sch, Pittsburgh, PA 15213 USA
[2] Harvard Univ, Sch Med, Dept Med, Decis Syst Grp,Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Tufts Univ, Div Clin Decis Making Informat & Telemed, New England Med Ctr, Dept Med,Sch Med,Tupper Res Inst, Boston, MA 02111 USA
关键词
hip fracture; cost; decision analysis; morbidity; mortality; nursing home;
D O I
10.1046/j.1532-5415.2003.51110.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To estimate lifetime morbidity, mortality, and costs from hip fracture incorporating the effect of deficits in activities of daily living. DESIGN: Markov computer cohort simulation considering short- and long-term outcomes attributable to hip fractures. Data estimates were based on published literature, and costs were based primarily on Medicare reimbursement rates. SETTING: Postacute hospital facility. PARTICIPANTS: Eighty-year-old community dwellers with hip fractures. MEASUREMENTS: Life expectancy, nursing facility days, and costs. RESULTS: Hip fracture reduced life expectancy by 1.8 years or 25% compared with an age- and sex-matched general population. About 17% of remaining life was spent in a nursing facility. The lifetime attributable cost of hip fracture was $81,300, of which nearly half (44%) related to nursing facility expenses. The development of deficits in ADLs after hip fracture resulted in substantial morbidity, mortality, and costs. CONCLUSION: Hip fractures result in significant mortality, morbidity, and costs. The estimated lifetime cost for all hip fractures in the United States in 1997 likely exceeded $20 billion. These results emphasize the importance of current and future interventions to decrease the incidence of hip fracture.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 64 条
[1]  
*AM AC ORTH SURG, 1992, MUSC COND US
[2]  
Beck T S, 1996, Am J Orthop (Belle Mead NJ), V25, P608
[3]   Supplemental calcium for the prevention of hip fracture: Potential health-economic benefits [J].
Bendich, A ;
Leader, S ;
Muhuri, P .
CLINICAL THERAPEUTICS, 1999, 21 (06) :1058-1072
[4]   A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS [J].
BERLIN, JA ;
LAIRD, NM ;
SACKS, HS ;
CHALMERS, TC .
STATISTICS IN MEDICINE, 1989, 8 (02) :141-151
[5]   FACTORS ASSOCIATED WITH SHORT-TERM VERSUS LONG-TERM SKILLED NURSING FACILITY PLACEMENT AMONG COMMUNITY-LIVING HIP FRACTURE PATIENTS [J].
BONAR, SK ;
TINETTI, ME ;
SPEECHLEY, M ;
COONEY, LM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (10) :1139-1144
[6]   The economic cost of hip fractures in community-dwelling older adults: A prospective study [J].
Brainsky, A ;
Glick, H ;
Lydick, E ;
Epstein, R ;
Fox, KM ;
Hawkes, W ;
Kashner, TM ;
Zimmerman, SI ;
Magaziner, J .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (03) :281-287
[7]   HIP FRACTURE - A PROSPECTIVE-STUDY OF HOSPITAL COURSE, COMPLICATIONS, AND COSTS [J].
CAMPION, EW ;
JETTE, AM ;
CLEARY, PD ;
HARRIS, BA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1987, 2 (02) :78-82
[8]   COSTS AND HEALTH-EFFECTS OF OSTEOPOROTIC FRACTURES [J].
CHRISCHILLES, E ;
SHIREMAN, T ;
WALLACE, R .
BONE, 1994, 15 (04) :377-386
[9]   The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial [J].
Chrischilles, EA ;
Dasbach, EJ ;
Rubenstein, LM ;
Cook, JR ;
Tabor, HK ;
Black, DM .
OSTEOPOROSIS INTERNATIONAL, 2001, 12 (08) :654-660
[10]   TARGETED ESTROGEN PROGESTOGEN REPLACEMENT THERAPY FOR OSTEOPOROSIS - CALCULATION OF HEALTH-CARE COST SAVINGS [J].
CLARK, AP ;
SCHUTTINGA, JA .
OSTEOPOROSIS INTERNATIONAL, 1992, 2 (04) :195-200